Oversight of prescription drug plan sponsors' compliance plans.

Saved in:

Bibliographic Details
Corporate Author:	United States. Department of Health and Human Services. Office of Inspector General (Author)
Language:	English
Published:	[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2008.
Subjects:	Medicare. Centers for Medicare & Medicaid Services (U.S.) > Auditing. Pharmaceutical services insurance > United States > Auditing.
Online Access:	Connect to online resource - All users (Federal Depository Library Program Persistant URL)
Physical Description:	1 online resource (iii, 14 pages) : illustrations
Variant Title:	Oversight of prescription drug plan sponsors' compliance plans
Format:	Government Document Electronic eBook

Similar Items

Medicare drug plan sponsors' identification of potential fraud and abuse.
Published: (2008)

CMS's implementation of safeguards during fiscal year 2006 to prevent and detect fraud and abuse in Medicare prescription drug plans.
Published: (2007)

Audits of Medicare prescription drug plan sponsors.
Published: (2011)

Review of the relationship between Medicare Part D payments to local, community pharmacies and the pharmacies' drug acquisition costs
Published: (2008)

Improper payments for evaluation and management services cost Medicare billions in 2010.
Published: (2014)

Inconsistent Medicare data concerning carrier payment dates.
Published: (2000)

CMS did not administer and manage strategic communications services contracts in accordance with federal requirements.
Published: (2020)

CMS regularly reviews part C reporting requirements data, but Its followup and use of the data are limited.
Published: (2014)

Fiscal intermediary fraud units.
Published: (1998)

Carrier fraud units.
Published: (1996)

Recovery audit contractors' fraud referrals.
Published: (2010)

Marketing materials for Medicare prescription drug plans.
Published: (2008)

Limitations in manufacturer reporting of average sales price data for Part B drugs.
Published: (2014)

Early alert memorandum : payments to Medicare suppliers and home health agencies associated with "currently not collectible" overpayments.
Published: (2008)

Medicare's currently not collectible overpayments.
Published: (2013)

External quality reviews in Medicaid managed care
Published: (2008)

Prescription drug plan sponsors' compliance plans.
Published: (2006)

Centers for Medicare & Medicaid Services audits of Medicare Part D bids.
Published: (2008)

Carriers still need to purge unused provider numbers.
Published: (1995)

Medicare enrollment of home health providers.
Published: (2002)

Memorandum report : Medicare payments for Part B claims with G modifiers.
Published: (2013)

Drug manufacturers' noncompliance with average manufacturer price reporting requirements.
Published: (2010)

Average sales prices : manufacturer reporting and CMS oversight.
Published: (2010)

Compounded drugs under Medicare Part B : payment and oversight.
Published: (2014)

Missouri claimed unallowable federal reimbursement for some Medicaid physician-administered drugs.
Published: (2015)

Medicaid managed care encounter data : collection and use.
Published: (2009)

Deficiency history and recertification of Medicare home health agencies.
Published: (2008)

Zone program integrity contractors' data issues hinder effective oversight.
Published: (2011)

CMS has not performed required closeouts of contracts worth billions.
Published: (2015)

Calculation of volume-weighted average sales price for Medicare Part B prescription drugs.
Published: (2006)

Carrier determination of copayments for Medicare mental health services.
Published: (2006)

Centers for Medicare & Medicaid Services audits of Medicare Part D bids.
Published: (2008)

Duplicate Medicare payments by individual carriers.
Published: (2001)

Medicaid drug price comparisons : average sales price to average wholesale price.
Published: (2005)

Comparing pharmacy reimbursement : Medicare Part D to Medicaid.
Published: (2009)

CMS Is taking steps to improve oversight of provider-based facilities, but vulnerabilities remain.
Published: (2016)

Medicare carriers' policies for transcranial dopplers : a new technology.
Published: (1993)

Marketplaces faced early challenges resolving inconsistencies with applicant data.
Published: (2014)

Omission of drugs from the federal upper limit list in 2001.
Published: (2004)

Medicaid drug price comparisons : average manufacturer price to published prices.
Published: (2005)